Literature DB >> 12677704

[Barrett esophagus: epidemiology, incidence of carcinoma, need for screening].

R Arnold1, M Wied.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12677704     DOI: 10.1007/s00108-002-0813-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  39 in total

1.  A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance.

Authors:  S Gudlaugsdottir; M van Blankenstein; J Dees; J H Wilson
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-06       Impact factor: 2.566

2.  Barrett's esophagus: age, prevalence, and extent of columnar epithelium.

Authors:  A J Cameron; C T Lomboy
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

3.  Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.

Authors:  V N Shirvani; R Ouatu-Lascar; B S Kaur; M B Omary; G Triadafilopoulos
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

4.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 5.  The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction.

Authors:  S J Spechler
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

6.  Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.

Authors:  F T Peters; S Ganesh; E J Kuipers; W J Sluiter; E C Klinkenberg-Knol; C B Lamers; J H Kleibeuker
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

7.  Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.

Authors:  R E Rudolph; T L Vaughan; B E Storer; R C Haggitt; P S Rabinovitch; D S Levine; B J Reid
Journal:  Ann Intern Med       Date:  2000-04-18       Impact factor: 25.391

8.  Adenocarcinoma in Barrett's oesophagus: an overrated risk.

Authors:  A H Van der Veen; J Dees; J D Blankensteijn; M Van Blankenstein
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

9.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.

Authors:  W K Hirota; T M Loughney; D J Lazas; C L Maydonovitch; V Rholl; R K Wong
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

10.  Adenocarcinoma of the oesophagus and ectopic gastric mucosa.

Authors:  B C MORSON; J R BELCHER
Journal:  Br J Cancer       Date:  1952-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.